참고문헌
- Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126(3 Suppl):311S-7S.
- Ban-Hoefen M, Francis C. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital. Thromb Res 2009;124:189-92. Epub 2009 Feb 4. https://doi.org/10.1016/j.thromres.2009.01.006
- Refaai MA, Van Cott EM, Laposata M. The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases. Am J Clin Pathol 2003;119:497-504. https://doi.org/10.1309/KM2Y9H9TP6DA59MT
- Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2003; 2:148-57.
- Swan SK, Hursting MJ. The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender and hepatic or renal dysfunction. Pharmacotherapy 2000;20:318-29. https://doi.org/10.1592/phco.20.4.318.34881
- Levine RL, Hursting MJ, David McCollum MS. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction. Chest 2006;129;1167-75. https://doi.org/10.1378/chest.129.5.1167
- Lubenow N, Selleng S, Wollert HG, Eichler P, Mullejans B, Greinacher A. Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use. Ann Thorac Surg 2003;75:577-9. https://doi.org/10.1016/S0003-4975(02)04309-6
- Martin ME, Kloecker GH, Laber DA. Argatroban for anticoagulation during cardiac surgery. Eur J Haematol 2007;78: 161-6.